Evidence & regulatory context
- Mechanism
- S/B remedy, hot-water extract of Scutellaria baicalensis and Bupleurum (simplified Sho-Saiko-To); herbal formula.
- Target
- Not recorded
- Injury models
- Spinal cord injury
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatSpinal cord injuryContusionSprague-Dawleyfemaleintraperitoneal2 or 20 mg/kg, then 2 or 20 mg/kg/dayFirst dose 30 min before injury; a separate group received 20 mg/kg starting af…
Model: Severe contusive spinal cord injury using the NYU weight-drop device, 10 g rod dropped from 50 mm onto the T9-T10 dorsal cord after T9 laminectomy
S/B at 20 mg/kg improved BBB hindlimb scores to 5 weeks and reduced ED-1 expression and spinal lactate, with a non-significant trend to preserved neurofilament-L and reduced malondialdehyde, whereas 2 mg/kg had no effect.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.